In June, 2016, the Centers for Disease Control and Prevention (CDC) first identified Candida auris (C. auris) as an emerging fungal infection that presents a serious global health threat because is spreads in healthcare facilities and is often drug resistant. By August 2016, seven cases of multidrug-resistant C. auris infection had been diagnosed in the United States. A Morbidity and Mortality Weekly Report (MMWR) study reports that as of May 12, 2017, a total of 77 U.S. clinical cases of C. auris had been reported to CDC from seven states: New York, New Jersey, Illinois, Indiana, Maryland, Massachusetts, and Oklahoma. CDC’s C. auris website offers question and answer pages for patients and family members and for healthcare workers, and interim recommendations for healthcare facilities and laboratories. Read the MMWR study.